Home
|
Survey
|
Payment
|
Talks & Presentations
|
Job Opportunities
Journals
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Clinical Medication Journal
1672-3384
2008 Issue 6
The clinical analysis of 26 patients with anti-neutrophil cytoplasmic autoantibodies-related vasculitis
Tang Yan-chun;Yang Shu-qin;Liu Ying
..............
page:38-43
Relief severe pain in oral cavity caused by chemothery and radiation injury in cancer patients with transdermal fentanyl
Lu Chong;Liu Kui-feng;Shu Yang-chun;Wang Xin-ning;Wang Xi-cheng;Wen Zong-qiu
..............
page:43-46
The Effect and Side-effect of Protein Assimilation Drugs
Zhou Bing
..............
page:47-48
Bare Side-Effects Caused by Montelukast
Pei Zhen-e
..............
page:49-51
Therapeutic regimen analysis of an acute bronchial asthma case
Cheng Zhen-tian;Li Yan-ming;Ji Li-wei;Zhang Ya-tong;Liu Zhi-jun
..............
page:52-55
On the Clinical Pharmaceutical Care by One Case
Jiang Jun
..............
page:55-57
Clinical Use of Transdermal Drug Delivery System
Wu Jiu-hong;Xue Ke-chang
..............
page:58-62
Pharmacothcrapy of ANCA Associatedsm All Vasculitis
Wu Qing-jun;Tang Fu-lin
..............
page:33-37
Evidence-based Medicine and Its New Development
Zhan Si-yan
..............
page:30-32
Evaluating Coronary Drugs Potency by Evidence-based Medicine
Shi Hai-ming
..............
page:26-29,51
The Application of Antidepressant Drugs in Androcentric Diseases Treatment
Li Hong-jun
..............
page:21-25,37
Overview of the Treatment for Neuromyelitis Optica
Zhao Mang-suo;Geng Tong-chao
..............
page:17-21
The Treating Direction of Clinic Lipid Controlling Drugs
Zhao Wang;Zhao Shui-ping
..............
page:14-16
ENHANCE Research: What We Obtain in the Cognition of Lipid Metabolism?
Cheng Yuan-zhi
..............
page:11-13
Innovative Evidence and Strategy in Curing Hypertension
Guo Dan-jie
..............
page:8-11
HYVET——A Milestone of Treating the Aged Hypertension Patient
Zhu Wen-ling
..............
page:6-8
Multiple Choices in Forcible Lipid Control for High-risk/Very High-risk Patient——Will It Be Changed That the Combination of Statins and Ezefimibe Would Usher in A New Situation
Xu Cheng-bin
..............
page:1-5